206 related articles for article (PubMed ID: 12453439)
1. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
2. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
3. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
Tarui T; Miles LA; Takada Y
J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
[TBL] [Abstract][Full Text] [Related]
4. Angiostatin binds ATP synthase on the surface of human endothelial cells.
Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
[TBL] [Abstract][Full Text] [Related]
6. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
7. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
[TBL] [Abstract][Full Text] [Related]
8. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.
Hanford HA; Wong CA; Kassan H; Cundiff DL; Chandel N; Underwood S; Mitchell CA; Soff GA
Cancer Res; 2003 Jul; 63(14):4275-80. PubMed ID: 12874037
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen and angiostatin interact with heat shock proteins.
Dudani AK; Mehic J; Martyres A
Mol Cell Biochem; 2007 Jun; 300(1-2):197-205. PubMed ID: 17206383
[TBL] [Abstract][Full Text] [Related]
11. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
12. Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.
Richardson M; Gunawan J; Hatton MW; Seidlitz E; Hirte HW; Singh G
Gynecol Oncol; 2002 Sep; 86(3):279-87. PubMed ID: 12217749
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
14. Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH.
Wahl ML; Grant DS
Gen Pharmacol; 2000 Nov; 35(5):277-85. PubMed ID: 11888684
[TBL] [Abstract][Full Text] [Related]
15. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
16. Annexin II: a plasminogen-plasminogen activator co-receptor.
Kim J; Hajjar KA
Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
[TBL] [Abstract][Full Text] [Related]
17. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin-like molecules are generated by snake venom metalloproteinases.
Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
[TBL] [Abstract][Full Text] [Related]
20. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
Kost C; Benner K; Stockmann A; Linder D; Preissner KT
Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
